Registered entities
Veracyte Inc.
Reg. No. 146286091United States
Veracyte, Inc.
Reg. No. 1384101United States
Veracyte, Inc.
Reg. No. 20-5455398Belgium
Innovation
40 patent families (22 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace steady. Cited 19,415 times.
| Year | Filings |
|---|---|
| 2015 | 5 |
| 2016 | 7 |
| 2017 | 11 |
| 2018 | 12 |
| 2019 | 9 |
| 2020 | 18 |
| 2021 | 10 |
| 2022 | 10 |
| 2023 | 8 |
| 2024 | 12 |
| 2025 | 11 |
| 2026 | 4 |
Social engagement
Social engagement: 30.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include Domain Associates, General Electric; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 58% |
| Private equity | 2 | 17% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 2 | 17% |
Hiring activity
Hires periodically
8 roles tracked across 5 of the last 12 months
31 Mar 2026 · NetSuite Analyst · San Diego
2 Feb 2026 · Clinical Lab Scientist ll - 3rd Shift · San Diego
30 Jan 2026 · Financial Analyst · San Diego
26 Jan 2026 · Medical Science Liaison · San Francisco
6 Dec 2025 · Contract Software QA Engineer · South San Francisco
Based on job postings tracked across public sources.
Recent activity
16 Jun 2026
Event
High-Risk Breast Cancer Management with Test-Directed Chemotherapy webinar
11 Jun 2026
Event
ENDO2026 Annual Meeting
8 Jun 2026
Product launch
Prosigna® Breast Risk of Recurrence (ROR) test